Hi — I handle bulk & wholesale for this oil. Ask me anything, or tap a question below.
What the research says
More than a carrier. And we cite every word.
People reach for Hemp Seed for more than one thing. Here’s what the published studies actually found — graded honestly, each one linked.
13
uses studied
18
papers cited
0
hidden from you
What the published studies found
Traditional · 3 studies
Burns/Wound Healing
No clinical studies evaluate hemp seed oil for burns or wound healing. The retrieved literature documents only traditional use of Cannabis sativa roots (a different plant part than seed oil) for wounds, burns, and inflammation, alongside preclinical findings that cannabis smoke impairs bone healing in rats and in-vitro work on CBD/THC unrelated to topical wound care.
The retrieved literature addresses cannabidiol (CBD) and other cannabinoids from Cannabis sativa, with narrative reviews and in-vitro studies showing CBD can inhibit sebocyte lipid production and Cutibacterium acnes-induced inflammation in keratinocytes. Critically, hemp seed oil contains negligible-to-no cannabinoids, and no clinical trials testing hemp seed oil itself for acne were identified; any benefit is only mechanistically plausible via its high linoleic acid content, not evidence-based.
The only directly relevant study is preclinical: trilinolein, a triacylglycerol isolated from Cannabis sativa fruit (hemp seed), improved DNCB-induced atopic dermatitis-like lesions in mice and reduced oxidative stress in keratinocytes via the AhR-Nrf2 pathway, with efficacy comparable to crisaborole. No human clinical trials, RCTs, or systematic reviews on hemp seed oil for eczema were identified.
The retrievable evidence consists of an in vitro study showing cannflavin isolated from Cannabis sativa inhibits prostaglandin E2 production in cultured rheumatoid synovial cells, and a computational network-pharmacology analysis predicting phytocannabinoid targets in rheumatoid arthritis. Critically, neither study examines hemp seed oil itself—hemp seeds contain negligible cannabinoids or cannflavins—and no human clinical trials support hemp seed oil for joint inflammation.
The only identifiable relevant evidence is a single in-vitro study showing cannabidiol (CBD)—a compound found in negligible amounts in hemp seed oil—delayed senescence in cultured mesenchymal stem cells via SIRT1 and autophagy pathways. No human clinical trials, RCTs, or dermatological studies of topical or oral hemp seed oil for skin aging or wrinkles were found in the results provided.
The retrieved literature discusses the endocannabinoid system and cannabinoids from Cannabis sativa broadly as potential anxiolytic targets, but does not address hemp seed oil specifically. Hemp seed oil contains negligible cannabinoids (CBD/THC), and no clinical trials of hemp seed oil itself for anxiety or stress were identified in the provided results.
The only relevant publication is a narrative review documenting that folk medicine practitioners in Bangladesh traditionally use Cannabis sativa for dandruff, mentioned once among many ailments (n=1 citation). No clinical trials, controlled studies, or in-vitro research specifically evaluating hemp seed oil for dandruff was found.
Although 10 PMIDs were returned, only one full record was analyzable, and it is an in-vitro HaCaT keratinocyte study of cannabinoid-rich Cannabis sativa inflorescence extract (not hemp seed oil) showing anti-inflammatory effects and upregulation of skin barrier/moisturizing proteins (filaggrin, involucrin) relevant to atopic dermatitis. No human clinical trials of hemp seed oil for dry skin appear in the provided results.
The only identifiable relevant evidence is a single in-vitro study in which a cannabinoid ester (4-terpinyl cannabinolate) isolated from high-potency Cannabis sativa showed moderate activity against Candida albicans (IC50 8.5 µg/mL). Critically, this compound is found in the plant's resinous flowers, not in hemp seed oil—which is composed of fatty acids and contains negligible cannabinoids—so there is no direct evidence supporting hemp seed oil itself for fungal infections.
The retrieved literature concerns phytocannabinoids from Cannabis sativa (e.g., CB2 receptor docking and ex vivo nasal permeation relevant to migraine), not hemp seed oil specifically; the most relevant assessable study is in silico/ex vivo, and no clinical trials have tested hemp seed oil—which contains negligible cannabinoids—for headache or migraine.
A 2021 in-vitro study (PMID 34870017) found that phenethyl cinnamamides isolated from defatted hemp seed extract—particularly N-trans-caffeoyltyramine (IC50 0.8 μM)—inhibited tyrosinase activity and α-MSH-induced melanogenesis in B16F10 melanoma cells, leading authors to propose cosmetic skin-whitening potential. However, this evidence is preclinical only, used solvent fractions of seed extract rather than hemp seed oil itself, and no animal or human clinical trials exist for hyperpigmentation.
The only relevant study identified is a preclinical investigation in which hemp seed oil (HSO) was used as a penetration-enhancing component of a film-forming transdermal delivery system for cannabidiol (CBD); adding HSO improved CBD delivery and reduced writhing episodes in a mouse pain model (18.5 vs. 9.5 writhes). No human clinical trials were found evaluating hemp seed oil itself as a treatment for muscle pain, and the animal model used (writhing test) assesses visceral/inflammatory pain rather than muscle pain specifically.
The single assessable result (of 19 PMIDs reportedly returned) is a 2022 narrative review of cannabinoid-based products for inflammatory skin diseases, which describes promising preliminary findings for psoriasis but stresses that controlled human clinical trials are still lacking. Critically, this evidence concerns cannabinoids (CBD/THC) from Cannabis sativa flowers/leaves, not hemp seed oil, which contains negligible cannabinoids—so no direct clinical evidence supports hemp seed oil itself for psoriasis.
